Search

everythinglearnresearchcommunity

for

Search:↓

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Early intervention and patient education are crucial for managing alopecia areata.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Different parts of the body have unique immune characteristics in their skin.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Mogamulizumab can cause hair loss and skin rashes.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.